US2017252391A1PendingUtilityA1
Single herb extract for the treatment of pcos (poly cystic ovarian syndrome)
Est. expiryDec 16, 2034(~8.4 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 15/08A61P 15/00A61K 31/7048A61K 36/48A61K 9/0053A61K 9/48
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Discloses is a single herb extract for the treatment of PCOS (Poly Cystic Ovarian Syndrome) when given in oral dosage form as capsules of 500 mg, twice a day for period of time ranging from 30-90 days, The extract is obtained from fenugreek seeds using a specific method of extraction and comprises five furostanolicsaponins present in synergistic ratios as in Table 1 and having analytical profile as in FIG. 1.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A single herb extract obtained from fenugreek seeds, for the treatment of PCOS (polycystic ovarian syndrome) wherein the same comprises a synergistic mixture of five furostanolicsaponins as given in FIG. 1 and Table 1.
2 . The herbal extract of claim I for treatment of PCOS wherein the effective dosage is one gram per day in form of capsules of 500 mg twice a day for a period of time ranging from 30-90 days, depending upon individual response and clinical assessment.Join the waitlist — get patent alerts
Track US2017252391A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.